Princeton Capital Management Inc’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Princeton Capital Management Inc’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-4	Closed	-$16K	–	71
2014 Q2	$16K	Hold	4	–	–	0.01%	70
2014 Q1	$17K	Hold	4	–	–	0.01%	73
2013 Q4	$15K	Sell	4 -19	-83%	-$72K	0.01%	72
2013 Q3	$91K	Hold	23	–	–	0.08%	67
2013 Q2	$228K	Buy	+23	New	+$255K	0.22%	63

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SGAM

Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return

Princeton Capital Management Inc's FRTX Position: Q3 2014 in Review

Princeton Capital Management Inc sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2014, closing a stake of 4 shares — an estimated $16K sold.

Princeton Capital Management Inc first reported a position in FRTX in Q2 2013 and held it in 5 quarters. The position peaked at $228K in Q2 2013. 60 funds tracked by Wall St. Rank hold FRTX as of Q3 2014.

Princeton Capital Management Inc reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
Princeton Capital Management Inc sold 4 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $16K.
Princeton Capital Management Inc first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 5 quarters.
Princeton Capital Management Inc's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $228K in Q2 2013.
60 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2014.

Based on Princeton Capital Management Inc's 13F filing for Q3 2014, filed 5 Nov 2014.